Drug intelligence / Profile preview

ethinyl estradiol + ethynodiol diacetate

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

**Ethinyl estradiol + ethynodiol diacetate** is a combination oral contraceptive containing two hormones: ethinyl estradiol (a synthetic estrogen) and ethynodiol diacetate (a synthetic progestin)[1][5][6]. It is used primarily for the **prevention of pregnancy** in women who choose oral contraceptives[1][2][6]. This combination prevents ovulation by suppressing the secretion of gonadotropins (FSH and LH); additionally, it alters cervical mucus to hinder sperm passage and changes the endometrial lining to reduce the likelihood of implantation[1][5][6]. It is formulated as monophasic oral tablets, usually with 21 hormone-containing and 7 inert tablets per cycle[5][8]. No contraceptive method is 100% effective and this medication does not protect against STIs[6]. Rarely, it may be used for management of hormonally related conditions (e.g., acne) when contraception is also desired[7]. The drug contains active ingredients known by their chemical names: ethinyl estradiol (19-nor-17\u03b1-pregna-1,3,5(10)-trien-20-yne-3,17-diol) and ethynodiol diacetate (19-nor-17\u03b1-pregn-4-en-20-yne-3\u03b2,17-diol diacetate)[1][2].

Brand names
Demulen 1/35Demulen 1/50Kelnor 1/35Kelnor 1/50Kelnor 1/35-28Zovia 1/35Zovia 1/35EZovia 1/50EValtya 1/35Valtya 1/50
Other names
ethynodiol diacetate and ethinyl estradiolEthynodiol/Ethinyl Estradiol
02

Targets

ESR2 (ERβ)PR (Progesterone receptor)ESR1 (ERα)

Beyond the preview

Go deeper on ethinyl estradiol + ethynodiol diacetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethinyl estradiol + ethynodiol diacetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call